Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kaleido BioSciences

Kaleido BioSciences
2015 FOUNDED
PUBLIC STATUS
101-200 EMPLOYEES
KLDO STOCK SYMBOL
$5.27 SHARE PRICE (As of Monday Closing)
Description

Kaleido Biosciences Inc is a clinical-stage healthcare company. It is focused on leveraging the potential of the microbiome organ to treat disease and improve human health. Its product candidates are Microbiome Metabolic Therapies, or MMTs, which are designed to modulate the metabolic output and profile of the microbiome.

Website
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Stock Exchange
NAS
Primary Office
  • 18 Crosby Drive
  • Bedford, MA 01730
  • United States

+1 (617) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kaleido BioSciences’s full profile, request a free trial.

Kaleido BioSciences Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$4.80 - $19.00 $157M $5.05 -$3.78 71.1K 29.8M

Kaleido BioSciences Financials Summary

In Thousands,
USD
TTM
30-Jun-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 239,361
Revenue 0 0 0 0
EBITDA (83,160) (61,065) (26,840) (9,445)
Net Income (83,494) (61,744) (27,559) (9,685)
Total Assets 109,997 85,325 30,747 4,990
Total Debt 14,945 14,922 14,914 4,951
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Kaleido BioSciences Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore Kaleido BioSciences‘s full profile, request access.

Request full access to PitchBook

Kaleido BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is reserved for PitchBook Platform users. To explore Kaleido BioSciences‘s full profile, request access.

Request full access to PitchBook
To view this company’s complete Cap Table, request access »

Kaleido BioSciences Competitors (35)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Finch Therapeutics Venture Capital-Backed Somerville, MA 00 00000 00000000000 00000
00000000 000000000 Formerly VC-backed Rehovot, Israel 00 000.00 000000000 000.00
00000000000 Venture Capital-Backed South San Francisco, CA 00 000.00 00000000000 000.00
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 00000000000 00000
To view this company’s complete list of competitors, request access »

Kaleido BioSciences Investors

Investor Name Investor Type Holding Participating Rounds Investor Since Board Seat Contact Info

This information is reserved for PitchBook Platform users. To explore Kaleido BioSciences‘s full profile, request access.

Request full access to PitchBook

Kaleido BioSciences Executive Team (17)

Name Title Board
Seat
Contact
Info
Alison Lawton Chief Executive Officer & Board Member
Rob Miller Ph.D President of Nutrition
Joshua Brumm Chief Financial Officer & Chief Operating Officer
John Davies Ph.D Chief Technology Officer
Johan van Hylckama Vlieg Ph.D Chief Scientific Officer

6 Former Executives

You’re viewing 5 of 17 executives. Get the full list »

Kaleido BioSciences Board Members (15)

Name Representing Role Since Contact
Info
Alison Lawton Kaleido BioSciences Chief Executive Officer & Board Member 000 0000
Anthony Quinn Ph.D Self Board Member 000 0000
Geoffrey von Maltzahn Ph.D Self Board Member 000 0000
Grady Burnett Self Board Member 000 0000
Jean Mixer Self Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 15 board members. Get the full list »